S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Secret Bull Market Starts in This Unusual Sector (Ad)
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
The only accurate crypto trading system I know … (Ad)
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
New York goes dark, then America. (Ad)
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Secret Bull Market Starts in This Unusual Sector (Ad)
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
The only accurate crypto trading system I know … (Ad)
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
New York goes dark, then America. (Ad)
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Secret Bull Market Starts in This Unusual Sector (Ad)
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
The only accurate crypto trading system I know … (Ad)
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
New York goes dark, then America. (Ad)
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Secret Bull Market Starts in This Unusual Sector (Ad)
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
The only accurate crypto trading system I know … (Ad)
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
New York goes dark, then America. (Ad)
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
Free Trial
NASDAQ:HCWB

HCW Biologics (HCWB) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)
Free HCWB Stock Alerts
$1.53
-0.13 (-7.83%)
(As of 04/19/2024 ET)
Compare
Today's Range
$1.52
▼
$1.57
50-Day Range
$1.12
▼
$1.77
52-Week Range
$0.91
▼
$2.32
Volume
1,426 shs
Average Volume
7,921 shs
Market Capitalization
$57.86 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media
HCWB stock logo

About HCW Biologics Stock (NASDAQ:HCWB)

HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, which is in Phase 1 clinical chemo-refractory/chemo-resistant solid tumors with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as Phase 2 clinical trial with metastatic advanced stage ovarian cancer patients; and HCW9302 for autoimmune and proinflammatory diseases, such as alopecia areata diseases. It also develops HCW9201, a cell-based therapy that is in Phase I clinical trials for the treatment of patients with relapsed/refractory acute myelogenous leukemia; and HCW9206, an injectable immunotherapeutic to use as adjuvant for adoptive cell therapy in cancer treatment. HCW Biologics Inc. was incorporated in 2018 and is headquartered in Miramar, Florida.

HCWB Stock Price History

HCWB Stock News Headlines

April 2, 2024 | investorplace.com
HCWB Stock Earnings: HCW Biologics Misses EPS, Misses Revenue for Q4 2023
April 1, 2024 | globenewswire.com
HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights
April 20, 2024 | Altimetry (Ad)
Secret Bull Market Starts in This Unusual Sector
"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.
February 24, 2024 | finance.yahoo.com
Rebecca Byam Bought 122% More Shares In HCW Biologics
January 25, 2024 | finance.yahoo.com
Several Insiders Invested In HCW Biologics Flagging Positive News
November 17, 2023 | markets.businessinsider.com
HCW Biologics Receives Buy Rating: Strong Financial Position and Promising Clinical Data Validate Investment Opportunity
November 15, 2023 | markets.businessinsider.com
Analysts Are Bullish on Top Healthcare Stocks: HCW Biologics (HCWB), Urogen Pharma (URGN)
November 14, 2023 | finanznachrichten.de
HCW Biologics, Inc: HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlights
April 20, 2024 | Altimetry (Ad)
Secret Bull Market Starts in This Unusual Sector
"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.
November 14, 2023 | msn.com
HCW Biologics GAAP EPS of -$0.14, revenue of $174.77M
November 14, 2023 | finance.yahoo.com
HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlights
November 11, 2023 | morningstar.com
ADMA Biologics Inc ADMA
November 11, 2023 | morningstar.com
HCW Biologics Inc HCWB
November 11, 2023 | markets.businessinsider.com
Promising Phase 1 Results and Potential Synergies with PD-1 Inhibitors Bolster Buy Rating for HCW Biologics
November 8, 2023 | finance.yahoo.com
Investigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting
November 6, 2023 | finance.yahoo.com
Samsung Biologics and Kurma Partners announce strategic partnership for development and manufacturing of biologics for Kurma's portfolio companies
November 1, 2023 | finance.yahoo.com
Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual Meeting
September 21, 2023 | seekingalpha.com
HCW Biologics director Gary Winer buys shares worth $3.3k - filing
September 16, 2023 | finance.yahoo.com
Insider Buying: CFO Rebecca Byam Acquires 5,000 Shares of HCW Biologics Inc
September 9, 2023 | finance.yahoo.com
Insider Buying: CFO Rebecca Byam Acquires 10,000 Shares of HCW Biologics Inc
September 6, 2023 | finance.yahoo.com
HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 – 13, 2023
August 18, 2023 | finance.yahoo.com
Insider Stock Buying Reaches US$845k On HCW Biologics
August 15, 2023 | markets.businessinsider.com
Analysts Offer Insights on Healthcare Companies: HCW Biologics (HCWB) and Cochlear Limited (OtherCHEOF)
August 11, 2023 | finanznachrichten.de
HCW Biologics, Inc: HCW Biologics Reports Second Quarter 2023 Financial Results and Recent Business Highlights
August 11, 2023 | markets.businessinsider.com
Analysts Offer Insights on Healthcare Companies: HCW Biologics (HCWB) and Arrowhead Pharmaceuticals (ARWR)
August 11, 2023 | finance.yahoo.com
HCW Biologics Reports Second Quarter 2023 Financial Results and Recent Business Highlights
July 7, 2023 | finance.yahoo.com
The past year for HCW Biologics (NASDAQ:HCWB) investors has not been profitable
See More Headlines
Receive HCWB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HCW Biologics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/19/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:HCWB
CUSIP
N/A
CIK
1828673
Web
www.hcwbiologics.com
Phone
954-842-2024
Fax
954-842-2037
Employees
45
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.70)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-24,990,000.00
Net Margins
-879.49%
Pretax Margin
-879.45%
Return on Equity
-101.47%
Return on Assets
-67.94%

Debt

Debt-to-Equity Ratio
0.47
Current Ratio
0.73
Quick Ratio
0.73

Sales & Book Value

Annual Sales
$2.84 million
Price / Sales
20.37
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.37 per share
Price / Book
4.14

Miscellaneous

Outstanding Shares
37,820,000
Free Float
20,689,000
Market Cap
$57.86 million
Optionable
Not Optionable
Beta
0.97
7 Stocks to Buy And Hold Forever Cover
7 Stocks to Buy And Hold Forever

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Dr. Hing C. Wong Ph.D. (Age 70)
    Founder, CEO, Director & Secretary
    Comp: $421.05k
  • Ms. Rebecca Byam CPA (Age 68)
    M.B.A., Chief Financial Officer
    Comp: $297.08k
  • Dr. Peter Rhode Ph.D. (Age 66)
    Chief Scientific Officer & VP of Clinical Operations
    Comp: $248.57k
  • Ms. Nicole Valdivieso Esq.
    Vice President of Legal Affairs
  • Ms. Raquel Diaz M.S.
    Director of Human Resources
  • Mr. Lee D. Flowers (Age 78)
    Senior Vice President of Business Development

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

HCWB Stock Analysis - Frequently Asked Questions

How have HCWB shares performed in 2024?

HCW Biologics' stock was trading at $1.2250 at the start of the year. Since then, HCWB stock has increased by 24.9% and is now trading at $1.53.
View the best growth stocks for 2024 here.

When is HCW Biologics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our HCWB earnings forecast.

When did HCW Biologics IPO?

HCW Biologics (HCWB) raised $45 million in an initial public offering on Tuesday, July 20th 2021. The company issued 5,600,000 shares at a price of $8.00 per share. EF Hutton served as the underwriter for the IPO and Revere Securities was co-manager.

How do I buy shares of HCW Biologics?

Shares of HCWB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:HCWB) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
SHOCKING Crypto Leak…
Crypto 101 Media
Your Money is Not Safe
American Alternative
The #1 Crypto for 2024
InvestorPlace
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets